PLXP stock downgraded at Oppenheimer after Q2 miss (NASDAQ:PLXP)
Oppenheimer downgraded PLx Pharma (PLXP) to Perform from Outperform after the drug delivery platform company posted a larger than expected loss for Q2 2022 on Friday
PLXP stock downgraded at Oppenheimer after Q2 miss (NASDAQ:PLXP)
Oppenheimer downgraded PLx Pharma (PLXP) to Perform from Outperform after the drug delivery platform company posted a larger than expected loss for Q2 2022 on Friday